APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872,704 | -75.5% | 75,518 | -41.3% | 0.01% | -73.7% |
| Q2 2023 | $11,720,470 | +35.7% | 128,655 | -1.7% | 0.02% | +35.7% |
| Q1 2023 | $8,634,889 | +31.7% | 130,911 | +3.2% | 0.01% | +27.3% |
| Q4 2022 | $6,556,466 | -23.0% | 126,793 | +1.7% | 0.01% | -26.7% |
| Q3 2022 | $8,515,000 | +3447.9% | 124,671 | +2248.7% | 0.02% | – |
| Q2 2022 | $240,000 | -83.7% | 5,308 | -81.7% | 0.00% | -100.0% |
| Q1 2022 | $1,476,000 | +16.7% | 29,069 | +8.6% | 0.00% | +100.0% |
| Q4 2021 | $1,265,000 | – | 26,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |